10-Q: BIO-key International Reports Mixed Q1 2024 Results Amidst Restructuring Efforts

Sentiment:

Quarterly Report


BIO-key International's Q1 2024 results show a slight decrease in overall revenue, but a significant improvement in gross profit, alongside ongoing efforts to address internal control weaknesses.

Delay expectedThe company has purchased inventory for projects in Nigeria, which have been delayed in deployment.
Capital raiseThe company is dependent on debt and equity financing to fund its operations.The company may need to obtain additional third-party financing if it is unable to generate sufficient revenue to fund current operations.The company has historically financed its operations through access to the capital markets by issuing secured and convertible debt securities, convertible preferred stock, and common stock.
Worse than expectedAlthough the net loss improved, the company's overall revenue decreased slightly, and service revenue saw a significant decline.The company's negative working capital and ongoing losses indicate that the financial results were worse than expected.

Summary

  • BIO-key International reported a net loss of $510,285 for the first quarter of 2024, compared to a net loss of $1,688,322 for the same period in 2023.
  • Total revenue was $2,181,203, a slight decrease from $2,183,767 in Q1 2023.
  • License fee revenue increased by 24% to $1,950,434, while hardware revenue decreased by 76% to $17,647.
  • Service revenue decreased by 60% to $213,122, primarily due to the loss of a large customer service agreement and reduced custom service revenue.
  • Gross profit significantly improved to $1,881,560 from $863,493 in the prior year's quarter, due to reduced costs of license fees and hardware.
  • Operating expenses decreased to $2,390,494 from $2,621,891, with reductions in selling, general, and administrative expenses, as well as research and development costs.
  • The company's cash and cash equivalents increased to $690,449 from $511,400 at the end of the previous quarter.
  • The company has a negative working capital of approximately $1,048,000.
  • BIO-key is addressing material weaknesses in internal controls over financial reporting, particularly related to revenue recognition and inventory reserves.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive developments like improved gross profit and reduced losses, but significant concerns remain regarding revenue decline, negative working capital, and internal control weaknesses. The company's going concern status is also a major concern.

Positives

  • The company experienced a significant increase in license revenue, indicating strong demand for its software solutions.
  • Gross profit improved substantially, suggesting better cost management and pricing strategies.
  • Operating expenses were reduced, reflecting the company's efforts to streamline operations.
  • The net loss was significantly reduced compared to the same period last year, indicating progress towards profitability.
  • Cash and cash equivalents increased, providing some financial flexibility.

Negatives

  • Overall revenue saw a slight decrease, indicating challenges in maintaining consistent sales growth.
  • Hardware revenue experienced a significant decline, suggesting potential issues with hardware sales or demand.
  • Service revenue decreased substantially, highlighting the impact of losing a major customer and reduced custom service revenue.
  • The company has a negative working capital, indicating potential short-term liquidity issues.
  • The company is still experiencing a net loss, indicating that it is not yet profitable.

Risks

  • The company's ability to continue as a going concern is in doubt due to substantial net losses and negative cash flows.
  • The company is dependent on debt and equity financing to fund its operations.
  • There are material weaknesses in internal controls over financial reporting, particularly related to revenue recognition and inventory reserves.
  • The company faces risks related to customer concentration, with a few customers accounting for a significant portion of revenue and accounts receivable.
  • The company has a large amount of inventory purchased for projects in Nigeria that have been delayed, and the company is exploring other markets to sell this product.
  • The company's ability to generate sufficient revenue to fund current operations is uncertain.

Future Outlook

The company plans to expand its role in the IAM market, focusing on offering a suite of authentication options that complement its biometric solutions. They expect to grow their business within government services and highly-regulated industries. The company also plans to pursue strategic acquisitions in the IAM space.

Management Comments

  • The company is working to implement appropriate corrective actions to remediate the material weakness to strengthen our internal controls over the recording of revenues.
  • The company expects the service revenue to remain at the current lower rate in future periods.
  • The company is exploring other markets and opportunities to sell the product to generate additional cash.

Industry Context

The company operates in the growing identity and access management (IAM) market, which is seeing increased demand due to the adoption of multi-factor authentication (MFA) as a cybersecurity requirement. BIO-key differentiates itself by offering phone-less and token-less biometric solutions, which are particularly effective for environments with roving workers and shared workstations. The company's technology also plays a role in securing in-person identity, which is a unique offering in the market.

Comparison to Industry Standards

  • BIO-key's focus on biometric authentication aligns with the industry trend towards more secure and user-friendly authentication methods, however, many competitors are larger and more established.
  • Unlike many competitors that rely on phone-based or token-based MFA, BIO-key offers phone-less and token-less biometric options, which is a key differentiator.
  • The company's ability to support mixing and matching of different manufacturers' fingerprint scanners provides flexibility to customers, which is not always standard in the industry.
  • While BIO-key is expanding its channel partner program, it is still smaller than many of its competitors, which may limit its reach and market penetration.
  • The company's financial performance, particularly its ongoing losses and negative working capital, is a concern compared to more established and profitable competitors in the IAM space.

Stakeholder Impact

  • Shareholders face risks due to the company's ongoing losses, negative working capital, and potential need for additional financing.
  • Employees may be affected by cost-cutting measures and potential restructuring efforts.
  • Customers may experience changes in service delivery due to the company's financial challenges.
  • Suppliers and creditors face risks due to the company's financial instability and potential inability to meet obligations.

Next Steps

  • The company will continue to implement corrective actions to remediate material weaknesses in internal controls.
  • The company will explore other markets and opportunities to sell the inventory purchased for projects in Nigeria.
  • The company will continue to pursue strategic acquisitions of select businesses and assets in the IAM space.
  • The company will focus on increasing marketing efforts into the IAM market and growing its channel alliance program.

Key Dates

DateDescription
2022-12-22The company entered into a securities purchase agreement and issued a $2,200,000 senior secured promissory note.
2023-08-11The company signed a new one-year lease for office space in New Jersey.
2023-10-31The company repaid $1,400,000 of principal due under the senior secured promissory note.
2023-12-21The company repaid the remaining $800,000 principal balance of the senior secured promissory note.
2023-12-21BIO-key's 1-for-18 reverse stock split was effective.
2024-03-31End of the first quarter of 2024.
2024-05-06186 shares of restricted common stock were forfeited by an employee.
2024-06-12Number of shares of Common Stock outstanding is 1,814,228.
2024-06-14Date of filing of the quarterly report.

Keywords

biometrics, identity access management, IAM, multi-factor authentication, MFA, software, hardware, license fees, revenue, financial results, internal controls, cybersecurity, authentication, PortalGuard, Swivel Secure

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.